13-<it>cis</it>-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

13-<it>cis</it>-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

<p>Abstract</p> <p>In 30–50% of patients with metastatic non-medullary thyroid cancer the metastases are not radioiodine-avid and so there is no effective treatment. Retinoids have demonstrated inhibition of thyroid tumor growth and induction of radioiodine uptake. The aim of our s...

Full description

Bibliographic Details
Main Authors: Handkiewicz-Junak Daria, Roskosz Jozef, Hasse-Lazar Kornelia, Szpak-Ulczok Sylwia, Puch Zbigniew, Kukulska Aleksandra, Olczyk Tomasz, Piela Andrzej, Paliczka-Cieslik Ewa, Jarzab Barbara
Format: Article
Language:English
Published: BMC 2009-08-01
Series:Thyroid Research
Online Access:http://www.thyroidresearchjournal.com/content/2/1/8

Similar Items

Similar Items